Project Grant HT94252510294
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$999K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77204, USA
Similar Awards
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
The University of Houston System was awarded a $999,392 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective September 1, 2025 through August 31, 2029, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. Specifically, the grant will fund research on PRMT5 in lupus nephritis, aiming to advance disease prevention, diagnosis,...
The University of Houston was awarded a $749,981 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the molecular basis of blood-brain barrier breach in lupus from May 1, 2023 through April 30, 2026. As part of the Military Medical Research and Development program's goals of transforming health care for service members and investigating medical solutions for the battlefield,...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The Department of the Army Medical Command awarded a $300,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Tulane University to conduct research on determining risk factors for lupus nephritis through the intersection of glycobiology and immunometabolism. The award period runs from August 15, 2025 to August 14, 2027. Tulane University, a private non-profit research university, has extensive experience working with federal agencies on medical...
The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
The Department of the Army Medical Command awarded Monash University a $1,498,168 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Targeted Regulatory T Cells to Treat SLE from September 1, 2022 through August 31, 2025. Under this award, Monash University will conduct research to investigate medical solutions for systemic lupus erythematosus (SLE) by developing targeted regulatory T cells as an innovative treatment approach. The...
The Department of the Army Medical Command awarded a $1,499,782 Project Grant to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery under the Military Medical Research and Development program. This three-year award beginning July 1, 2022 will support research into photosensitivity and lymph node immune responses in lupus. The Military Medical Research and Development program aims to advance biomedical research that improves health care for...
The Department of the Army Medical Command awarded a $750,000 Project Grant to The Trustees of Columbia University in the City of New York under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant aims to validate Systemic Lupus Erythematosus (SLE) virtual outcome measures through three specific objectives over a three-year period ending August 2024. Sub-awards were provided to six institutions, including the Oklahoma Medical Research Foundation and the...